Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Morning post by Oncy on X (Twitter)

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Mar 01, 2024 10:39am

102 Views

Post# 35909089

RE:RE:RE:RE:RE:RE:RE:Morning post by Oncy on X (Twitter)

A quick look at Calgary departures yesterday shows no major scheduling disruptions (despite a late day snow storm).

I don't care enough to look at the connections to New Orleans.

I'll wait till someone else does before calling out ONC's bullsh*t amateurish conduct.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season